Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Researchers establish the effect of beta-blocker nebivolol on nitric oxide production

Aug. 21, 2000

Therapies aimed at reducing free radicals may innovate treatment of septic shock

Aug. 21, 2000

Smoking linked to increased TF expression in atherosclerotic plaques

Aug. 21, 2000

GenVec begins phase II trials of BioByPass in PVD

Aug. 18, 2000

Novel endothelin receptor antagonists under study at BASF

Aug. 16, 2000

Prous Science selected official internet and multimedia provider for XXII ESC Congress

Aug. 11, 2000

Carvedilol surpasses metoprolol in long-term heart failure treatment

Aug. 11, 2000

Prous Science selected official internet and multimedia provider for XXII ESC Congress

Aug. 10, 2000

ATP-regulated potassium channel modulators under development at Novo Nordisk

Aug. 10, 2000

Roche discloses new series of IP receptor agonists

Aug. 9, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...